Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,651 - 1,675 of 2,875 « 1 … 65 66 67 68 69 … 115 » Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care J. Marie Suga, MD View Video EGFR & ALK: Where are We Now? Jacob Sands, MD View PDF ALK-Altered Non-Squamous NSCLC: Options and Sequence Jacob Sands, MD View Video EGFR & ALK: Where Are We Now? Jacob Sands, MD View Video Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 1) Janakiram Subramanian, MD View PDF Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK Janakiraman Subramanian MD View PDF Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK Janakiraman Subramanian MD View Video Adjuvant and Neo-adjuvant Therapy for Lung Cancer Janakiraman Subramanian MD, MPH View PDF Adjuvant and Neo-adjuvant Therapy for Lung Cancer Janakiraman Subramanian MD, MPH View Video Immunotherapy in Lung Cancer Janakiraman Subramanian, MD View PDF Predictive Biomarkers for SCLC Janakiraman Subramanian, MD View PDF Predictive Biomarkers for SCLC Janakiraman Subramanian, MD View Video SCLC & Squamous NSCLC - New Standards Janakiraman Subramanian, MD, MPH View PDF Small Cell and Neuroendocrine Carcinoma of The Lung Janakiraman Subramanian, MD, MPH View PDF Uncommon Mutations: RET, MET, NTRK, & BRAF Janakiraman Subramanian, MD, MPH View PDF RET, MET & B-RAF mutations in NSCLC Janakiraman Subramanian, MD, MPH View PDF RET, MET & B-RAF mutations in NSCLC Janakiraman Subramanian, MD, MPH View Video Managing Toxicities from TKI EGFR and ALK Inhibitors Jane Arboleda, APRN View PDF The Era of Antibody Drug Conjugates in NSCLC Targeting Her-2, CEACAM5, TROP-2, and MET Jason Porter, MD View PDF Small Cell Lung Cancer Jason Porter, MD View PDF The Era of Antibody Drug Conjugates in NSCLC Targeting Her-2, CEACAM5, TROP-2, and MET Jason Porter, MD View Video Small Cell Lung Cancer Jason Porter, MD View Video Target Therapy Updates in Lung Cancer 2024 JASON PORTER, MD View PDF Best Surgical Approaches for Stage III NSCLC Jay M. Lee, MD View PDF Best Surgical Approaches for Stage III NSCLC Jay M. Lee, MD View Video
